Brent Pfeiffenberger

Brent Pfeiffenberger

Amministratore Delegato presso CENTURY THERAPEUTICS, INC.

Patrimonio netto: 4 M $ in data 30/06/2024

46 anni
Health Technology

Provenienza dei contatti di primo grado di Brent Pfeiffenberger

EntitàTipo di entitàSettore Industriale
Public Company Biotechnology 14
1
Subsidiary Biotechnology 1

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Brent Pfeiffenberger tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
CELGENE Biotechnology

Adrienne Farid

Gregory Russotti

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Timothy Walbert

Douglas Carr

Corporate Officer/Principal

Corporate Officer/Principal

ROCHE HOLDING AG Pharmaceuticals: Major

Franz Humer

Hyam Levitsky

Chairman

Corporate Officer/Principal

Pharmaceuticals: Major

Franz Humer

Hyam Levitsky

Chief Operating Officer

Corporate Officer/Principal

AGENUS INC. Biotechnology

Hyam Levitsky

Director/Board Member

Miscellaneous Commercial Services

Hyam Levitsky

Adrienne Farid

Corporate Officer/Principal

Corporate Officer/Principal

AMICUS THERAPEUTICS, INC. Pharmaceuticals: Major

Mike Diem

Daphne Quimi

Corporate Officer/Principal

Director of Finance/CFO

NUPATHE INC Medical Specialties

Mike Diem

Director/Board Member

Biotechnology

Mike Diem

Director/Board Member

AILERON THERAPEUTICS, INC. Pharmaceuticals: Major

Mike Diem

Director/Board Member

Pharmaceuticals: Major

Douglas Carr

Comptroller/Controller/Auditor

Miscellaneous Commercial Services

Mike Diem

Carlo Rizzuto

Director/Board Member

Director/Board Member

NOVARTIS AG Pharmaceuticals: Major

Joseph Jimenez

Alessandro Riva

Chief Executive Officer

Corporate Officer/Principal

Investment Managers

Mike Diem

Private Equity Analyst

Miscellaneous Commercial Services

Daphne Quimi

Corporate Officer/Principal

Medical/Nursing Services

Hyam Levitsky

Corporate Officer/Principal

Rutgers State University of New Jersey College/University

Mike Diem

Douglas Carr

Gregory Russotti

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

The Johns Hopkins University College/University

Hyam Levitsky

Corporate Officer/Principal

Monmouth University College/University

Daphne Quimi

Undergraduate Degree

Investment Managers

Mike Diem

Private Equity Investor

Pharmaceuticals: Major

Joseph Jimenez

Alessandro Riva

Carlo Rizzuto

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Zocor Ltd.

Douglas Carr

Corporate Officer/Principal

Pharmaceuticals: Major

Mike Diem

Director/Board Member

Investment Managers

Mike Diem

Private Equity Analyst

Pharmaceuticals: Major

Timothy Walbert

Joseph Jimenez

Director/Board Member

Chairman

Miscellaneous Commercial Services

Hyam Levitsky

Corporate Officer/Principal

Miscellaneous Commercial Services

Hyam Levitsky

Corporate Officer/Principal

Miscellaneous Commercial Services

Joseph Jimenez

Franz Humer

President

Corporate Officer/Principal

Biotechnology

Hyam Levitsky

Corporate Officer/Principal

Hospital/Nursing Management

Hyam Levitsky

Corporate Officer/Principal

Pharmaceuticals: Major

Franz Humer

Chairman

KITE PHARMA INC Biotechnology

Cynthia Butitta

Franz Humer

Director of Finance/CFO

Director/Board Member

Glaxo Pharmaceuticals UK Ltd.

Franz Humer

Chief Executive Officer

The Johns Hopkins University School of Medicine College/University

Hyam Levitsky

Doctorate Degree

JUNO THERAPEUTICS INC Biotechnology

Hyam Levitsky

Chief Tech/Sci/R&D Officer

School of Engineering & Applied Science College/University

Hyam Levitsky

Undergraduate Degree

Investment Managers

Franz Humer

Director/Board Member

REPLIMUNE GROUP, INC. Biotechnology

Hyam Levitsky

Director/Board Member

Medical/Nursing Services

Franz Humer

Chairman

Miscellaneous Commercial Services

Hyam Levitsky

Director/Board Member

ALLOGENE THERAPEUTICS, INC. Biotechnology

Franz Humer

Director/Board Member

Financial Conglomerates

Franz Humer

Chairman

Medical Specialties

Franz Humer

Chairman

CARISMA THERAPEUTICS, INC. Biotechnology

Hyam Levitsky

Adrienne Farid

Director/Board Member

Director/Board Member

Novira Therapeutics, Inc.

Douglas Carr

Corporate Officer/Principal

Heritage Conservancy

Douglas Carr

Director/Board Member

Statistiche

Distribuzione geografica

Stati Uniti 39
Regno Unito 5
Svizzera 4
Germania 3
Francia 2

Settori

Health Technology 26
Commercial Services 8
Finance 6
Consumer Services 6
Health Services 4

Posizioni

Director/Board Member 112
Corporate Officer/Principal 68
Independent Dir/Board Member 43
Chairman 25
Chief Executive Officer 21